Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The Telomere Crisis: A Crucial Stage in Breast Cancer

11.08.2004


A schematic representation of the genomic events associated with breast cancer progression, including the occurrence of telomere crisis.


These confocal microscope images highlight regions of chromosomes in cells of a breast duct exhibiting hyperplasia (left) and one exhibiting carcinoma in situ (right).


Telomere crisis is an important early event in the development of breast cancer, and its occurrence can be identified with precision, according to recent findings by a team of scientists at the Department of Energy’s Lawrence Berkeley National Laboratory and the University of California at San Francisco. Their report is now available through advance online publication of Nature Genetics.

Joe Gray, director of Berkeley Lab’s Life Sciences Division and a professor of laboratory medicine and radiation oncology at UCSF, is one of the paper’s lead authors, with Koei Chin and Britt Marie Ljung of UCSF; Carlos Ortiz de Solorzano, Paul Yaswen, and Martha Stampfer of Berkeley Lab; and Stephen J. Lockett from the National Cancer Institute.

In the breast, cells in a milk-collecting duct occasionally proliferate excessively due to development of a regulatory defect. Gray and his colleagues postulate that this results in a lesion called "usual ductal hyperplasia."



"The chromosomes in these growing cells lose a hundred or so base pairs of DNA every time they divide," Gray explains, "because the usual DNA replication processes don’t copy DNA all the way out to the ends of the chromosomes. This erodes the DNA sequences that interact with proteins to form structures called telomeres, which protect the chromosome ends."

Eventually the DNA ends erode so much they can no longer protect the chromosomes. When this happens the chromosomes become unstable, and damage-control mechanisms kick in that kill the unstable cells. This process, known as "telomere crisis," normally protects against inappropriate long-term cell growths like cancer.

Gray and his colleagues believe that "very rarely, the chromosome instability activates a specialized DNA-replication complex, telomerase, which can restore telomeres. Cells in which telomerase is activated can then proliferate indefinitely to form the next stage of cancer, known as ’ductal carcinoma in situ.’" Should the cancer progress further, it next invades other parts of the breast and may escape to other organs.

Not all cancer researchers agree that telomere crisis in hyperplasia, followed by reactivation of telomerase, leads to carcinoma in situ — and thence, sometimes, to invasive cancer; they assign cancer to other causes. Partly the disagreement arises because sequential events can’t be followed in individual tissue samples from living subjects.

"In human studies, the order from normal ducts, to ductal hyperplasia, to ductal carcinoma in situ, to invasive cancer is just association," says Gray, "because we can’t look at the same tissue all the way through the crisis."

Therefore the researchers compared the assumed sequence of events in tissue with what happened when they induced a culture of human mammary epithelial cells, HMEC, derived from normal breast tissue, to undergo telomere crisis and immortalization. Says Gray, "With HMEC in vitro we can follow the progression all the way through crisis, compare this to what we observe in actual tissue specimens from patients, and see if they are similar."

Using 3-D confocal microscopy and working first with breast-cancer tissue samples, at each stage the researchers assessed genomic instability and such correlated features as the amount of DNA content, signs of rearranged chromosomes, and the number of copies of genes known to play a role in cancer. These measures increased, on average, from the hyperplasia stage to the invasive cancer stage.
They also measured mean telomere lengths of cells at each stage. They found that mean telomere length decreased from normal tissue to carcinoma in situ, and decreased even more in invasive cancers.

When they looked at cultured human mammary cells, the researchers found a remarkably similar series. To induce telomeric crisis and subsequent immortalization in these cells, they introduced a known breast cancer gene into the culture and examined progressive generations of cells.

Telomere length decreased steadily. Genome instability and evidence of rearranged chromosomes were low before telomere crisis — just as in the tissue samples of usual ductal hyperplasia — and highest during the crisis, as in the samples of ductal carcinoma in situ. Instability then decreased, and changes in genome complexity leveled off, as in invasive cancer tissues — where critically short telomeres are presumably maintained by reactivated telomerase.

The mammary cell culture studies also confirmed that the probability of successful passage through the telomere crisis is low — most cells damaged because of shortened telomeres can’t evade cell death. In fact, women with usual ductal hyperplasia are only slightly more at risk of developing invasive cancer. When carcinoma in situ does form, it is probably from a single cell that has managed to reactivate telomerase.

"Our research establishes two things," Gray says. "First is that telomere crisis does appear to play an important role in the development of most breast cancers. Second is where it occurs: at the transition from hyperplasia to carcinoma in situ."

These findings suggest that people at higher risk of developing cancer can be identified in advance by measuring telomerase activity, genome instability, and other signals in the clinic.

The findings also point to possible ways of stopping cancer by derailing transition through the telomere crisis (rare as successful transition is): by using drugs that maintain the cell’s damage-control mechanisms, for example, or that prevent telomerase reactivation or that poison cells in which telomerase is already active. Some of these possible preventive agents are already being tested.

Paul Preuss | EurekAlert!
Further information:
http://www.lbl.gov

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>